Longitudinal medication profile and cost savings in Parkinson ’s disease patients after bilateral subthalamic nucleus deep brain stimulation

ConclusionSTN DBS led to LEDD reduction and antiparkinsonian medication cost savings in our South-East Asian cohort. Medication reduction with STN DBS in our cohort over the 10-year period was comparable to those reported in Western populations.
Source: Journal of Neurology - Category: Neurology Source Type: research